# Tharimmune Inc. (THAR)

Source: https://www.quantisnow.com/company/THAR
Generated: 2026-11-04T13:03:54.546Z

- Ticker: THAR
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2022

## Latest THAR news and filings

- 2026-02-18 13:45 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-amendments-to-articles-of-6398458)
- 2026-02-17 12:10 UTC [Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy](https://www.quantisnow.com/insight/tharimmune-inc-announces-corporate-rebrand-to-canton-strategic-holdings-inc-6394174)
- 2026-02-11 22:20 UTC [SEC Form 3] [SEC Form 3 filed by new insider Radkowski Angela Dominy](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-radkowski-angela-dominy-6387378)
- 2026-02-11 22:18 UTC [SEC Form 3] [SEC Form 3 filed by new insider Sommers Jill E.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-sommers-jill-e-6387356)
- 2026-02-11 22:16 UTC [SEC Form 3] [SEC Form 3 filed by new insider Wiley William Thomas Jr.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-wiley-william-thomas-6387339)
- 2026-02-11 22:14 UTC [SEC Form 3] [SEC Form 3 filed by new insider Asbury Jacob](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-asbury-jacob-6387321)
- 2026-02-06 21:01 UTC [SEC Form SCHEDULE 13G filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-tharimmune-inc-6379626)
- 2026-02-06 13:20 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6379115)
- 2026-02-06 13:15 UTC [Leadership Update] [Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer](https://www.quantisnow.com/insight/tharimmune-inc-appoints-mark-wendland-chairman-of-the-board-and-6379103)
- 2026-02-03 16:39 UTC [SEC Form SCHEDULE 13G filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-tharimmune-inc-6371771)
- 2026-02-03 02:26 UTC [SEC Form SCHEDULE 13G filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-tharimmune-inc-6370927)
- 2026-02-02 13:20 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-submission-of-matters-to-6369176)
- 2026-02-02 13:15 UTC [Leadership Update] [Tharimmune Elects Jill Sommers and William Wiley to Board of Directors](https://www.quantisnow.com/insight/tharimmune-elects-jill-sommers-and-william-wiley-to-board-of-6369166)
- 2026-01-27 02:51 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-tharimmune-inc-6361319)
- 2026-01-26 13:50 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-financial-statements-and-exhibits-6360234)
- 2026-01-22 21:12 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-entry-into-a-material-6357778)
- 2026-01-22 21:12 UTC [Public Offering] [Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering](https://www.quantisnow.com/insight/tharimmune-inc-announces-closing-of-55-million-underwritten-registered-direct-6357777)
- 2026-01-20 15:52 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-financial-statements-and-exhibits-6353770)
- 2026-01-20 14:05 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-tharimmune-inc-6353598)
- 2026-01-20 13:45 UTC [Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering](https://www.quantisnow.com/insight/tharimmune-inc-announces-pricing-of-55-million-underwritten-registered-offering-6353481)
- 2026-01-20 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-tharimmune-inc-6352973)
- 2026-01-16 21:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-tharimmune-inc-6352041)
- 2026-01-15 21:10 UTC [SEC Form 8-K] [SEC Form 8-K filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-tharimmune-inc-6350828)
- 2026-01-09 21:34 UTC [SEC Form S-3] [SEC Form S-3 filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-tharimmune-inc-6344579)
- 2026-01-06 21:37 UTC [SEC Form PRER14A filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-prer14a-filed-by-tharimmune-inc-6338924)
- 2025-12-18 13:15 UTC [Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network](https://www.quantisnow.com/insight/tharimmune-inc-statement-on-dtccs-initiative-to-tokenize-us-treasury-6321350)
- 2025-12-18 02:28 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-tharimmune-inc-6321075)
- 2025-12-17 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-tharimmune-inc-6318927)
- 2025-12-16 21:20 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-tharimmune-inc-6318128)
- 2025-12-12 13:45 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-leadership-update-regulation-fd-6313513)
- 2025-12-12 13:15 UTC [Leadership Update] [Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy](https://www.quantisnow.com/insight/tharimmune-inc-appoints-jacob-asbury-as-chief-financial-officer-to-6313425)
- 2025-12-05 21:52 UTC [SEC Form S-3] [SEC Form S-3 filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-tharimmune-inc-6305341)
- 2025-12-05 21:13 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-tharimmune-inc-6305072)
- 2025-11-28 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-tharimmune-inc-6295911)
- 2025-11-14 19:20 UTC [SEC Form 3] [SEC Form 3 filed by new insider Wendland Mark Paul](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-wendland-mark-paul-6280012)
- 2025-11-14 19:18 UTC [SEC Form 3] [SEC Form 3 filed by new insider Toomey Mark Christopher](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-toomey-mark-christopher-6280009)
- 2025-11-13 13:05 UTC [Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids](https://www.quantisnow.com/insight/tharimmune-receives-positive-fda-feedback-for-th104-prophylaxis-program-against-6276283)
- 2025-11-12 21:58 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Tharimmune Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-tharimmune-inc-6275206)
- 2025-11-10 22:31 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-leadership-update-6271530)
- 2025-11-07 02:50 UTC [SEC Form 8-K] [Tharimmune Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/tharimmune-inc-filed-sec-form-8-k-entry-into-a-material-6267010)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/THAR
- Earnings history: https://www.quantisnow.com/earnings/THAR
- Dividend history: https://www.quantisnow.com/dividends/THAR
- Insider transactions: https://www.quantisnow.com/insiders/THAR
- Options chain: https://www.quantisnow.com/options/THAR
- SEC 8-K filings only: https://www.quantisnow.com/company/THAR/8-k
- RSS and alerts for THAR: https://www.quantisnow.com/docs/rss-feeds.md